Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Refractory Status Epilepticus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with refractory status epilepticus not due to cerebral anoxia, needing coma induction for clinical management.~Exclusion Criteria:~* Age \< 16 years old.~* Known pregnancy.~* Cerebral anoxia as SE etiology.~* Epilepsia partialis continua (simple partial SE).~* Known intolerance to the study drugs.~* Known mitochondrial disorder, hyperlipidemia, or significant rhabdomyolysis.

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): propofol, 2mg/kg as bolus, then titrated up to EEG burst-suppression as a continuous infusion; no maximum doses defined
- 2 (Type: ACTIVE_COMPARATOR): thiopental/pentobarbital, 2mg/kg as bolus, then titrated up to EEG burst-suppression as a continuous infusion; no maximum doses defined

Based on this trial design, predict the completion outcome and termination type (if applicable).